Cargando…

Prognostic significance of peritoneal metastasis from colorectal cancer treated with first-line triplet chemotherapy

BACKGROUND: Peritoneal metastasis from colorectal cancer (CRC) carries a poor prognosis in most studies. The majority of those studies used either a single-agent or doublet chemotherapy regimen in the first-line setting. AIM: To investigate the prognostic significance of peritoneal metastasis in a c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bazarbashi, Shouki, Alghabban, Abdulrahman, Aseafan, Mohamed, Aljubran, Ali H, Alzahrani, Ahmed, Elhassan, Tusneem AM
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Clinical Trials Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968618/ https://www.ncbi.nlm.nih.gov/pubmed/35434075 http://dx.doi.org/10.12998/wjcc.v10.i8.2429

Ejemplares similares

The Significance of Sidedness in Patients with Metastatic Colorectal Cancer Treated with Triplet First-Line Chemotherapy
por: Bazarbashi, Shouki, et al.
Publicado: (2019)

Characteristics and treatment results of patients with gastroenteropancreatic neuroendocrine tumors in a tertiary care centre
por: Bazarbashi, Shouki, et al.
Publicado: (2023)

Survival benefit of surgical resection after first-line triplet chemotherapy and bevacizumab in patients with initially unresectable metastatic colorectal cancer
por: Elshenawy, Mahmoud A., et al.
Publicado: (2020)

Combining Sunitinib and Bevacizumab for the Management of Advanced Renal Cell Carcinoma: A Phase I/II Trial
por: Bazarbashi, Shouki, et al.
Publicado: (2023)

Phase I/II trial of capecitabine, oxaliplatin, and irinotecan in combination with bevacizumab in first line treatment of metastatic colorectal cancer
por: Bazarbashi, Shouki, et al.
Publicado: (2015)

Outcomes and Prognostic Factors of Metastatic Gastric Cancer: A Single-Center Experience
por: Aseafan, Mohamed, et al.
Publicado: (2022)

Thromboembolic Events Burden in Patients With Solid Tumors and Their Predisposing Factors
por: Bazarbashi, Shouki, et al.
Publicado: (2022)

Characteristics and outcomes of small bowel adenocarcinoma: 14 years of experience at a single tertiary hospital in Saudi Arabia
por: Alshamsan, Bader, et al.
Publicado: (2023)

Efficacy and Prognostic Factors of Sunitinib as First-Line Therapy for Patients With Metastatic Renal Cell Carcinoma in an Arab Population
por: Badran, Ahmed, et al.
Publicado: (2020)

Neoadjuvant concurrent chemoradiotherapy using infusional gemcitabine in locally advanced rectal cancer: A phase II trial
por: Bazarbashi, Shouki, et al.
Publicado: (2022)

Efficacy of Regorafenib in Metastatic Colorectal Cancer: A Multi-institutional Retrospective Study
por: Aljubran, Ali, et al.
Publicado: (2019)

Population-based survival for cancer patients in Saudi Arabia for the years 2005–2009
por: Aseafan, Mohamed, et al.
Publicado: (2022)

Recurrence and progression in nonmuscle invasive transitional cell carcinoma of urinary bladder treated with intravesical Bacillus Calmette–Guerin: A single center experience and analysis of prognostic factors
por: Bazarbashi, Shouki N., et al.
Publicado: (2016)

Utilization and cost of electronic resources in adult cancer center
por: Maraiki, Fatma, et al.
Publicado: (2018)

Outcomes of Patients with Metastatic Colorectal Cancer Treated with Trifluridine/Tipiracil beyond the Second Line: A Multicenter Retrospective Study from Saudi Arabia
por: Alghamdi, Mohammed, et al.
Publicado: (2022)

Why local guidelines?
por: Bazarbashi, Shouki
Publicado: (2011)

P788: OUTCOME OF SEVERE APLASTIC ANEMIA TREATED WITH ALLOGENIC STEM CELL TRANSPLANTATION COMPARED WITH IMMUNOSUPPRESSIVE THERAPY AS FIRST LINE.
por: Haroon, Alfadil, et al.
Publicado: (2023)

Saudi Oncology Society clinical management guidelines development
por: Bazarbashi, Shouki N.
Publicado: (2014)

A Trial Protocol of Biweekly TAS-102 and Bevacizumab as Third-Line Chemotherapy for Advanced/Recurrent Colorectal Cancer: A Phase II Multicenter Clinical Trial (The TAS-CC4 Study)
por: Yoshida, Yoichiro, et al.
Publicado: (2019)

Saudi Oncology Society clinical management guideline series: Colorectal cancer 2014
por: Bazarbashi, Shouki N., et al.
Publicado: (2014)

Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy for Management of Peritoneal Sarcomatosis: A Preliminary Single-Center Experience from Saudi Arabia
por: Abu-Zaid, Ahmed, et al.
Publicado: (2016)

Average duration of prior treatment lines predicts clinical benefit to eribulin chemotherapy in patients with metastatic breast cancer
por: Coe, Faye, et al.
Publicado: (2021)

Trastuzumab combined with doublet or single-agent chemotherapy as first-line therapy for HER2-positive metastatic breast cancer
por: Yu, Y. F., et al.
Publicado: (2017)

Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer with peritoneal metastasis
por: Lin, En-Kwang, et al.
Publicado: (2016)

Investigation of the effectiveness of hyperthermic intraperitoneal chemotherapy in experimental colorectal peritoneal metastasis model
por: Manoğlu, Berke, et al.
Publicado: (2023)

The influence on quality of life of intermittent scheduling in first- and second-line chemotherapy of patients with HER2-negative advanced breast cancer
por: Claessens, Anouk K. M., et al.
Publicado: (2019)

Colorectal cancer in Saudi Arabia: incidence, survival, demographics and implications for national policies
por: Alsanea, Nasser, et al.
Publicado: (2015)

77286 Intravital microscopy in the study of the tumor vasculature of patients with peritoneal carcinomatosis
por: Gabriel, Emmanuel, et al.
Publicado: (2021)

A Review of Clinical Studies and Practical Guide for the Administration of Triplet Chemotherapy Regimens with Bevacizumab in First-line Metastatic Colorectal Cancer
por: Loupakis, Fotios, et al.
Publicado: (2015)

Trends in Use and Perceptions About Triplet Chemotherapy Plus Bevacizumab for Metastatic Colorectal Cancer
por: van Nassau, Sietske C., et al.
Publicado: (2021)

Phase 3, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer: ENGOT-en9/LEAP-001
por: Marth, Christian, et al.
Publicado: (2022)

Systematic Review of Variations in Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Metastasis from Colorectal Cancer
por: Yurttas, Can, et al.
Publicado: (2018)

Cancer Incidence in Saudi Arabia: 2012 Data from the Saudi Cancer Registry
por: Bazarbashi, Shouki, et al.
Publicado: (2017)

Multimodality Treatment Including Triplet Regimen as First-Line Chemotherapy May Improve Prognosis of Serum AFP-Elevated Gastric Cancer with Liver Metastasis
por: Wang, Yakun, et al.
Publicado: (2017)

Saudi Oncology Society clinical management guideline series: Pancreatic cancer 2014
por: Rahal, Mohammed M., et al.
Publicado: (2014)

Hepatectomy Followed by Adjuvant Chemotherapy with 3‐Month Capecitabine Plus Oxaliplatin for Colorectal Cancer Liver Metastases
por: Satake, Hironaga, et al.
Publicado: (2021)

Abdominal tuberculosis mimicking peritoneal metastasis
por: Al Jazzar, Ragad I., et al.
Publicado: (2023)

A randomized controlled trial comparing primary tumour resection plus chemotherapy with chemotherapy alone in incurable stage IV colorectal cancer: JCOG1007 (iPACS study)
por: Moritani, Konosuke, et al.
Publicado: (2019)

Treatment for Peritoneal Metastasis of Patients With Colorectal Cancer
por: Kim, Young Jin, et al.
Publicado: (2021)

Methodological Approaches to Cost-Effectiveness Analysis in Saudi Arabia: What Can We Learn? A Systematic Review
por: Maraiki, Fatma, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h2gsli842mafu953ibarga876d